Prevalence of body iron excess in the metabolic syndrome

被引:144
作者
Bozzini, C
Girelli, D
Olivieri, O
Martinelli, N
Bassi, A
De Matteis, G
Tenuti, I
Lotto, V
Friso, S
Pizzolo, F
Corrocher, R
机构
[1] Univ Verona, Dept Clin & Expt Med, I-37134 Verona, Italy
[2] Univ Verona, Inst Clin Chem, I-37100 Verona, Italy
关键词
D O I
10.2337/diacare.28.8.2061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2061 / 2063
页数:3
相关论文
共 30 条
[1]   EASL International Consensus Conference on Haemochromatosis - Part II. Expert document [J].
Adams, P ;
Brissot, P ;
Powell, L .
JOURNAL OF HEPATOLOGY, 2000, 33 (03) :487-496
[2]  
Bozzini C, 2002, CLIN CHEM, V48, P622
[3]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[4]   Hepatic steatosis: A mediator of the metabolic syndrome. Lessons from animal models [J].
den Boer, M ;
Voshol, PJ ;
Kuipers, F ;
Havekes, LM ;
Romijn, JA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) :644-649
[5]   Serum ferritin as a component of the insulin resistance syndrome [J].
Fernández-Real, JM ;
Ricart-Engel, W ;
Arroyo, E ;
Balançá, R ;
Casamitjana-Abella, R ;
Cabrero, D ;
Fernández-Castañer, M ;
Soler, J .
DIABETES CARE, 1998, 21 (01) :62-68
[6]   Cross-talk between iron metabolism and diabetes [J].
Fernández-Real, JM ;
López-Bermejo, A ;
Ricart, W .
DIABETES, 2002, 51 (08) :2348-2354
[7]   Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes - The insulin resistance atherosclerosis study [J].
Festa, A ;
D'Agostino, R ;
Tracy, RP ;
Haffner, SM .
DIABETES, 2002, 51 (04) :1131-1137
[8]   Non-invasive assessment of hepatic iron stores by MRI [J].
Gandon, Y ;
Olivié, D ;
Guyader, D ;
Aubé, C ;
Oberti, F ;
Sebille, V ;
Deugnier, Y .
LANCET, 2004, 363 (9406) :357-362
[9]   Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation [J].
Ganz, T .
BLOOD, 2003, 102 (03) :783-788
[10]   Venesection therapy of insulin resistance-associated hepatic iron overload [J].
Guillygomarc'h, A ;
Mendler, MH ;
Moirand, R ;
Lainé, F ;
Quentin, V ;
David, V ;
Brissot, P ;
Deugnier, Y .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :344-349